Mereo Biopharma 2 Limited

09647035

active

Private Limited Company

england wales

Companies House

Health Score

65 / 100

Some Concerns

25/30

Filing

0/30

Financial

40/40

Risk

No risk factors detected.

Details

4TH FLOOR, ONE, LONDON, W1G 0QF

Incorporated 18/06/2015

Compliance

Last accounts

31/12/2024

small

Next accounts due

30/09/2026

On track

Confirmation statement

Last: 18/06/2025

Due 02/07/2026

On track

Industry

72110

Research and experimental development on biotechnology

Officers

Dr Denise Vera Scots-Knight

director · Since 18/06/2015

CEO

BRITISH · ENGLAND · Age 67

Also on 4 other boards

Mr Charles Edward Sermon

director · Since 30/06/2015

GENERAL COUNSEL

BRITISH · UNITED KINGDOM · Age 57

Also on 9 other boards

Ms Christine Ann Fox

director · Since 06/01/2021

CHIEF FINANCIAL OFFICER

AMERICAN · UNITED KINGDOM · Age 46

Also on 3 other boards

Persons with Significant Control

Mereo Biopharma Group Plc

75–100% shares

75–100% votes

Appoint directors

Fourth Floor, 1 Cavendish Place, London, W1G 0QF

Reg: 09481161 · Companies House · Public Limited Company

Notified 06/04/2016

Charges0 outstanding

Charge

satisfied

KREOS CAPITAL V (UK) LIMITED

Created 28/09/2018Registered 08/10/2018Satisfied 17/12/2020

Charge

satisfied

KREOS CAPITAL V (UK) LIMITED COMPANY NUMBER 09728300

Created 07/08/2017Registered 14/08/2017Satisfied 10/10/2018